X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31755) 31755
Newsletter (190) 190
Book Chapter (24) 24
Magazine Article (19) 19
Publication (10) 10
Conference Proceeding (9) 9
Book / eBook (6) 6
Dissertation (5) 5
Paper (4) 4
Web Resource (4) 4
Newspaper Article (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pyrimidines - pharmacology (17392) 17392
humans (16572) 16572
animals (14579) 14579
male (8116) 8116
pharmacology & pharmacy (6177) 6177
mice (6124) 6124
rats (5380) 5380
female (5221) 5221
pyrimidines (4656) 4656
pyrimidines - therapeutic use (3990) 3990
chemistry, medicinal (3835) 3835
oncology (3596) 3596
pyrimidines - chemistry (3555) 3555
biochemistry & molecular biology (3404) 3404
antineoplastic agents - pharmacology (3373) 3373
cell line, tumor (3370) 3370
imatinib mesylate (3353) 3353
structure-activity relationship (3025) 3025
piperazines - pharmacology (2961) 2961
dose-response relationship, drug (2929) 2929
pyrimidines - chemical synthesis (2717) 2717
benzamides (2710) 2710
protein kinase inhibitors - pharmacology (2675) 2675
cancer (2582) 2582
adult (2257) 2257
middle aged (2163) 2163
pyrimidines - administration & dosage (2127) 2127
analysis (2111) 2111
expression (1998) 1998
cells, cultured (1985) 1985
cell line (1926) 1926
cell proliferation - drug effects (1897) 1897
pyrazoles - pharmacology (1864) 1864
cell biology (1850) 1850
enzyme inhibitors - pharmacology (1847) 1847
apoptosis (1838) 1838
research (1818) 1818
phosphorylation (1781) 1781
apoptosis - drug effects (1770) 1770
molecular structure (1698) 1698
time factors (1586) 1586
activation (1574) 1574
pyrimidines - pharmacokinetics (1554) 1554
mutation (1547) 1547
pyrimidines - metabolism (1504) 1504
signal transduction - drug effects (1484) 1484
rats, sprague-dawley (1477) 1477
aged (1459) 1459
in-vitro (1433) 1433
neurosciences (1419) 1419
kinetics (1406) 1406
chemistry, organic (1402) 1402
in vitro techniques (1362) 1362
proteins (1360) 1360
hematology (1318) 1318
models, molecular (1312) 1312
inhibition (1306) 1306
signal transduction (1288) 1288
antineoplastic agents - therapeutic use (1287) 1287
pyrimidines - adverse effects (1280) 1280
triazoles - pharmacology (1264) 1264
cells (1259) 1259
cell survival - drug effects (1233) 1233
inhibitors (1221) 1221
piperazines - therapeutic use (1172) 1172
voriconazole (1145) 1145
pharmacology (1144) 1144
protein-tyrosine kinases - antagonists & inhibitors (1129) 1129
drug design (1109) 1109
pyridines - pharmacology (1105) 1105
imatinib (1103) 1103
disease models, animal (1090) 1090
pyrroles - pharmacology (1089) 1089
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1087) 1087
sulfonamides - pharmacology (1081) 1081
microbial sensitivity tests (1076) 1076
rats, wistar (1066) 1066
microbiology (1054) 1054
derivatives (1052) 1052
kinases (1002) 1002
treatment outcome (1001) 1001
drug synergism (1000) 1000
mice, inbred c57bl (980) 980
resistance (970) 970
chronic myeloid-leukemia (965) 965
pharmacokinetics (965) 965
research article (964) 964
dna (945) 945
tumor cells, cultured (940) 940
physiological aspects (936) 936
care and treatment (933) 933
enzymes (933) 933
gene expression (918) 918
nucleosides (906) 906
antifungal agents - pharmacology (901) 901
therapy (899) 899
drugs (889) 889
chemistry, multidisciplinary (885) 885
growth (876) 876
antineoplastic agents - chemical synthesis (874) 874
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30899) 30899
Japanese (593) 593
German (393) 393
Russian (196) 196
Chinese (154) 154
French (129) 129
Italian (68) 68
Spanish (50) 50
Polish (42) 42
Hungarian (15) 15
Ukrainian (15) 15
Czech (8) 8
Croatian (5) 5
Portuguese (5) 5
Romanian (5) 5
Bulgarian (4) 4
Turkish (4) 4
Norwegian (3) 3
Danish (2) 2
Dutch (2) 2
Swedish (2) 2
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 22, pp. 1665 - 1675
Recent advances in tumor biology have made remarkable achievements in the development of therapy for metastatic castrate-resistant prostate cancer. These... 
GROWTH-FACTOR RECEPTOR | CONTROLLED-TRIAL | ANTIANGIOGENIC THERAPY | ONCOLOGY | RANDOMIZED PHASE-II | BONE METASTASES | C-MET | SIPULEUCEL-T APC8015 | ABIRATERONE ACETATE | TUMOR MICROENVIRONMENT | ANGIOGENESIS INHIBITION | Cancer Vaccines - pharmacology | Humans | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Prostatic Neoplasms - immunology | RANK Ligand - pharmacology | Receptors, Androgen - drug effects | Treatment Failure | Prostatic Neoplasms - drug therapy | Phenylthiohydantoin - pharmacology | Tumor Microenvironment - drug effects | Dasatinib | Antibodies, Monoclonal - pharmacology | Angiogenesis Inhibitors - pharmacology | Clusterin - pharmacology | Pyrimidines - pharmacology | Denosumab | Prostate-Specific Antigen - blood | Orchiectomy | Signal Transduction - drug effects | Anilides - pharmacology | Mice | Receptor Cross-Talk - drug effects | Endothelin-1 - antagonists & inhibitors | Immunotherapy - methods | Taxoids - pharmacology | Ipilimumab | Tissue Extracts - pharmacology | Bone Remodeling - drug effects | Pyrrolidines - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Androstenols - pharmacology | Androstenes | Clinical Trials as Topic | Mice, SCID | Phenylthiohydantoin - analogs & derivatives | Biomarkers, Tumor - blood | Xenograft Model Antitumor Assays | Cancer Vaccines - immunology | Pyrroles - pharmacology | Animals | RANK Ligand - antagonists & inhibitors | Pyridines - pharmacology | Thiazoles - pharmacology | Immune response | Development and progression | Cellular signal transduction | Research | Drug therapy | Health aspects | Prostate cancer | Risk factors | Review
Journal Article
Drug metabolism and disposition, ISSN 1521-009X, 2012, Volume 40, Issue 9, pp. 1744 - 1756
Interindividual variability in activity of uptake transporters is evident in vivo, yet limited data exist in vitro, confounding in vitro-in vivo extrapolation.... 
DRUG TRANSPORTERS | IN-VITRO CLEARANCE | CRYOPRESERVED HUMAN HEPATOCYTES | HMG-COA REDUCTASE | PHARMACOLOGY & PHARMACY | ANION TRANSPORTING POLYPEPTIDES | HEPATIC-UPTAKE | HEALTHY-VOLUNTEERS | METABOLIC ENZYMES | RECEPTOR ANTAGONIST | PREDICTION | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Species Specificity | Valsartan | Hypoglycemic Agents - metabolism | Benzoates - metabolism | Humans | Antihypertensive Agents - metabolism | Hepatocytes - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 1 Receptor Blockers - metabolism | Organic Anion Transporters - metabolism | Pyrimidines - metabolism | Quinolines - pharmacology | Tetrazoles - metabolism | Carbamates - metabolism | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Biological Transport | Piperidines - pharmacology | Hepatocytes - drug effects | Carbamates - pharmacology | Pravastatin - pharmacology | Fluorobenzenes - metabolism | Piperidines - metabolism | Pravastatin - metabolism | Valine - analogs & derivatives | Rats | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Hypoglycemic Agents - pharmacology | Quinolines - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Valine - metabolism | Models, Biological | Benzimidazoles - metabolism | Sulfonamides - metabolism | Benzoates - pharmacology | Benzimidazoles - pharmacology | Kinetics | Valine - pharmacology | Organic Anion Transporters - drug effects
Journal Article
Nature communications, ISSN 2041-1723, 2014, Volume 5, Issue 1, p. 5712
Increased expression of the Microphthalmia-associated transcription factor (MITF) contributes to melanoma progression and resistance to BRAF pathway... 
BRAF INHIBITION | TYROSINE KINASE AXL | RAF INHIBITION | CELLS | BREAST-CANCER METASTASIS | MULTIDISCIPLINARY SCIENCES | ACQUIRED-RESISTANCE | IMPROVED SURVIVAL | MEK INHIBITORS | UP-REGULATION | CONFERS RESISTANCE | Prognosis | Skin Neoplasms - drug therapy | Humans | Gene Expression Regulation, Neoplastic | Extracellular Signal-Regulated MAP Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - genetics | Melanoma - genetics | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Indoles - pharmacology | Pyrimidinones - pharmacology | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Proto-Oncogene Proteins B-raf - metabolism | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Skin Neoplasms - pathology | Proto-Oncogene Proteins - antagonists & inhibitors | Microphthalmia-Associated Transcription Factor - metabolism | Signal Transduction | Proto-Oncogene Proteins - genetics | Imidazoles - pharmacology | Melanoma - pathology | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | Sulfonamides - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Skin Neoplasms - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Receptor Protein-Tyrosine Kinases - genetics | Proto-Oncogene Proteins B-raf - genetics | Aminopyridines - pharmacology | Melanoma - drug therapy | Skin Neoplasms - genetics | Cell Line, Tumor | Oximes - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Microphthalmia-Associated Transcription Factor - genetics | Pyridones - pharmacology
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 01/2013, Volume 304, Issue 1, pp. R23 - R32
The interaction between adenosine and soluble epoxide hydrolase (sEH) in vascular response is not known. Therefore, we hypothesized that lack of sEH in mice... 
Relaxation | CYP2J5-epoxgenase;ω-hydroxylase | receptor | Soluble epoxide hydrolase | Contraction | Adenosine A | Epoxide Hydrolases - physiology | Adenosine-5'-(N-ethylcarboxamide) - pharmacology | Butyrates - pharmacology | Male | Receptor, Adenosine A2A - physiology | Lauric Acids - pharmacology | Vasodilation - genetics | 8,11,14-Eicosatrienoic Acid - analogs & derivatives | Adenosine A2 Receptor Agonists - pharmacology | Urea - analogs & derivatives | Female | Benzamides - pharmacology | Oxygenases - physiology | Vasodilation - physiology | 8,11,14-Eicosatrienoic Acid - pharmacology | Adamantane - analogs & derivatives | NG-Nitroarginine Methyl Ester - pharmacology | Adamantane - pharmacology | Triazines - pharmacology | Phenethylamines - pharmacology | Vasodilator Agents - pharmacology | Enzyme Inhibitors - pharmacology | Gene Silencing | Adenosine - pharmacology | Pyrimidines - pharmacology | Epoxide Hydrolases - genetics | Triazoles - pharmacology | Adenosine A2 Receptor Antagonists - pharmacology | PPAR gamma - physiology | Animals | Adenosine - analogs & derivatives | Benzoates - pharmacology | Mice | Phenylurea Compounds - pharmacology | Pyridines - pharmacology | Vasodilation - drug effects | Urea - pharmacology | adenosine A2a receptor | CYP2J5-epoxgenase | ω-hydroxylase | relaxation | contraction | Cardiovascular and Renal Integration | soluble epoxide hydrolase | adenosine A1 receptor
Journal Article
Nature Neuroscience, ISSN 1097-6256, 03/2005, Volume 8, Issue 3, pp. 354 - 364
Microcircuits composed of principal neuron and interneuron dendrites have an important role in shaping the representation of sensory information in the... 
ACTION-POTENTIALS | NMDA RECEPTORS | GLOMERULAR LAYER | BULB | GABA RELEASE | CA2+ CHANNELS | CALCIUM CURRENT | DENDRODENDRITIC INHIBITION | T-TYPE | NEUROSCIENCES | SYNAPTIC ORGANIZATION | Calcium - metabolism | gamma-Aminobutyric Acid - metabolism | Membrane Potentials - radiation effects | Drug Interactions | Time Factors | Synaptic Transmission - drug effects | Neural Conduction - drug effects | Tetrodotoxin - pharmacology | Nickel - pharmacology | Olfactory Bulb - cytology | Animals, Newborn | Membrane Potentials - drug effects | Dendrites - drug effects | Calcium - pharmacology | Cadmium - pharmacology | Rats | Neural Conduction - physiology | Bicuculline - pharmacology | Chelating Agents - pharmacology | Pyrimidines - pharmacology | Potassium - pharmacology | Rats, Sprague-Dawley | GABA Antagonists - pharmacology | Signal Transduction - drug effects | Calcium Signaling - drug effects | Phosphinic Acids - pharmacology | Dihydropyridines - pharmacology | Neurons - radiation effects | Neural Conduction - radiation effects | Synaptic Transmission - physiology | Calcium Signaling - physiology | Neurons - cytology | Nimodipine - pharmacology | Patch-Clamp Techniques - methods | Diagnostic Imaging - methods | Dose-Response Relationship, Drug | Neural Inhibition - physiology | Neurons - physiology | Neurons - drug effects | Electric Stimulation - methods | Neural Networks (Computer) | Dendrites - metabolism | Synapses - physiology | Calcium Signaling - radiation effects | Valine - analogs & derivatives | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester - pharmacology | Calcium Channel Blockers - pharmacology | Membrane Potentials - physiology | Dendrites - radiation effects | Animals | Egtazic Acid - pharmacology | Synaptic Transmission - radiation effects | Calcium Channel Agonists - pharmacology | Signal Transduction - physiology | Valine - pharmacology | In Vitro Techniques | Propanolamines - pharmacology | Neural Inhibition - drug effects | Physiological aspects | Olfactory bulb | Cellular signal transduction | Neural circuitry | Research
Journal Article
Journal Article
Biochemical journal, ISSN 1470-8728, 2003, Volume 371, Issue 1, pp. 199 - 204
We have previously examined the specificities of 28 commercially available compounds, reported to be relatively selective inhibitors of particular... 
SELECTIVE-INHIBITION | ACTIVATION | VIVO | Src | protein kinase inhibitors | TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | protein phosphorylation | CYCLIN-DEPENDENT KINASES | GLYCOGEN-SYNTHASE KINASE-3-BETA | IN-VITRO | POTENT | SP 600125 | Roscovitine | Kenpaullone | LITHIUM | SMOOTH-MUSCLE CELLS
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2012, Volume 56, Issue 11, pp. 5898 - 5906
Epidemiological cutoff values (ECVs) for the species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not available. We established... 
Cryptococcus gattii/drug effects | India/epidemiology | Cryptococcosis/drug therapy | South America/epidemiology | Humans | Australia/epidemiology | Itraconazole/pharmacology | Microbial Sensitivity Tests | Pyrimidines/pharmacology | Triazoles/pharmacology | Fluconazole/pharmacology | Antifungal Agents/pharmacology | Europe/epidemiology | South Africa/epidemiology | Voriconazole | Drug Resistance, Fungal/drug effects | North America/epidemiology | MIC DISTRIBUTIONS | METHOD M38-A2 DOCUMENT | MOLECULAR TYPE | CROSS-RESISTANCE | CLSI BROTH MICRODILUTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | IN-VITRO SUSCEPTIBILITY | AMPHOTERICIN-B | ASPERGILLUS SPP | ANTIFUNGAL DRUG SUSCEPTIBILITY | LANOSTEROL 14-ALPHA-DEMETHYLASE | Fluconazole - pharmacology | Cryptococcosis - microbiology | Cryptococcosis - drug therapy | Fluconazole - therapeutic use | Itraconazole - pharmacology | Antifungal Agents - therapeutic use | Cryptococcus gattii - drug effects | South America - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Cryptococcus gattii - growth & development | Drug Resistance, Fungal - drug effects | South Africa - epidemiology | Europe - epidemiology | India - epidemiology | Pyrimidines - pharmacology | Australia - epidemiology | Itraconazole - therapeutic use | Triazoles - pharmacology | Cryptococcus gattii - isolation & purification | Pyrimidines - therapeutic use | Cryptococcosis - epidemiology | North America - epidemiology | Susceptibility
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 04/2012, Volume 287, Issue 15, pp. 11810 - 11819
gamma-Secretase-mediated cleavage of amyloid precursor protein (APP) results in the production of Alzheimer disease-related amyloid-beta (A beta) peptides. The... 
TARGET | PROTEIN | PATTERN | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSMEMBRANE DOMAIN | INHIBITORS | BINDING-SITES | EXPRESSION | FAILURE | PRESENILIN-1 | Pyridines - chemistry | Receptors, Notch - metabolism | Humans | Receptor, EphA4 - metabolism | Pyrimidines - chemistry | Brain - metabolism | Alanine - analogs & derivatives | Dibenzazepines - pharmacology | Drug Interactions | Azepines - chemistry | Piperidines - pharmacology | Protein Processing, Post-Translational - drug effects | Pyrans - chemistry | Amyloid beta-Protein Precursor - metabolism | HEK293 Cells | Female | Pyrans - pharmacology | Alanine - pharmacology | Carbamates - pharmacology | Binding, Competitive | Guinea Pigs | Amyloid beta-Peptides - biosynthesis | Dipeptides - pharmacology | Mice, Inbred C57BL | Rats | Imidazoles - pharmacology | Pyrimidines - pharmacology | Receptor, EphB2 - metabolism | Sulfonamides - pharmacology | Azepines - pharmacology | Brain - drug effects | Sulindac - analogs & derivatives | Amyloid Precursor Protein Secretases - metabolism | Animals | Cell-Free System | Protein Binding | Mice | Pyridines - pharmacology | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Flurbiprofen - pharmacology | Sulindac - pharmacology | Neurodegenerative Diseases | Secretases | Neurobiology | Intramembrane Proteolysis | Amyloid | Pharmacology | Alzheimer Disease
Journal Article